Education
About Us
Working with TipRanks
Follow Us
Avicanna Inc (TSE:AVCN)
:AVCN
AVCN Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.21 - C$0.45
Previous CloseN/A
Volume8.50K
Average Volume (3M)83.44K
Market Cap
C$30.20M
Enterprise ValueC$27.63M
Total Cash (Recent Filing)C$448.03K
Total Debt (Recent Filing)C$109.23K
Price to Earnings (P/E)―
Beta1.22
Next Earnings
Aug 18, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding111,860,725
10 Day Avg. Volume117,304
30 Day Avg. Volume83,445
Financial Highlights & Ratios
PEG Ratio-0.16
Price to Book (P/B)10.60
Price to Sales (P/S)0.00
P/FCF Ratio-9.29
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$0.49Price Target Upside76.14% Upside
Rating ConsensusHold
Number of Analyst Covering0
Avicanna News
PremiumCompany Announcements
Avicanna Closes $1 Million Private Placement to Boost Operations
PremiumCompany Announcements
Avicanna Secures Board Election and Auditor Reappointment at AGM
PremiumCompany Announcements
Avicanna Inc. Achieves First Profitable QuarterPremiumCompany Announcements
Avicanna Sponsors Phase II Clinical Study on Osteoarthritis Pain
PremiumCompany Announcements
Avicanna Achieves First Profitable Quarter in Q1 2025
PremiumCompany Announcements
Avicanna Inc’s Earnings Call Highlights Growth and ExpansionOptions Prices
Currently, No data available
---
Ownership Overview
33.07% Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
66.92% Public Companies and
Individual Investors
AVCN FAQ
What was Avicanna Inc’s price range in the past 12 months?
Avicanna Inc lowest stock price was C$0.21 and its highest was C$0.45 in the past 12 months.
What is Avicanna Inc’s market cap?
Avicanna Inc’s market cap is C$30.20M.
When is Avicanna Inc’s upcoming earnings report date?
Avicanna Inc’s upcoming earnings report date is Aug 18, 2025 which is in 24 days.
How were Avicanna Inc’s earnings last quarter?
Currently, no data Available
Is Avicanna Inc overvalued?
According to Wall Street analysts Avicanna Inc’s price is currently Undervalued.
Does Avicanna Inc pay dividends?
Avicanna Inc does not currently pay dividends.
What is Avicanna Inc’s EPS estimate?
Avicanna Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Avicanna Inc have?
Avicanna Inc has 111,860,725 shares outstanding.
What happened to Avicanna Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Avicanna Inc?
Currently, no hedge funds are holding shares in TSE:AVCN
Company Description
Avicanna Inc
Avicanna (AVCN) is a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products. The company operates in the sectors of pharmaceuticals, medical cannabis, and consumer products, offering a range of cannabinoid-based solutions for medical and wellness applications. Avicanna's core products include proprietary formulations for dermatology, neurology, and pain management, as well as consumer products under its RHO Phyto and Pura Earth brands.
Technical Analysis
MediPharm Labs
―
Decibel Cannabis Company
―
Rubicon Organics
―
Vext Science
―
Greenway Greenhouse Cannabis Corp.
―